Filiz Güldaval

Filiz Güldaval

Auto-generated profile, based on publicly available information

Filiz Güldaval

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İZMİR TIP FAKÜLTESİ, İZMİR TIP PR

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
FGFiliz Guldaval
Filiz Guldaval
GEGülru Erbay
Gülru Erbay
SDSibel Doruk
Sibel Doruk
GKGulistan Karadeniz
Gulistan Karadeniz
AAAYSU AYRANCI
AYSU AYRANCI
CACeyda Anar
Ceyda Anar
Chronic obstructive pulmonary disease,smoker,non-smoker

30 September 2019 in Tuberk Toraks
Verified
Journal Article
Closed access
NONeslihan OZCELIK
Neslihan OZCELIK
NANimet Aksel
Nimet Aksel
YBYılmaz Bülbül
Yılmaz Bülbül
YEYurnadur Erdoğan
Yurnadur Erdoğan
FGFiliz Güldaval
Filiz Güldaval
TÖTevfik Özlü
Tevfik Özlü
The results of standard chemotherapy in lung cancer are not very satisfactory, so it is important to identify genetic mutations that provide targeted therapies. Recent reports have suggested influences of racial difference on the frequency of mutation in lung cancer. We aimed to determine the frequency and regional distribution of genetic mutations of non-small cell lung cancer (NSCLC) in Turkey. Regional distribution of genetic mutations in lung cancer in Turkey (REDIGMA) study was carried out as a prospective, cross-sectional, observational study in a large number of centers in which lung cancer patients were followed and could perform genetic mutation analysis on patients' biopsy materials. The 703 patients (77.7% male, mean age 63.3 ± 12.5 years) who were diagnosed as NSCLC from 25 different centers were included in the study. Tumor samples from patients were reported as 87.1% adenocarcinoma, 6.4% squamous cell carcinoma and 6.5% other. Mutation tests were found to be positive in 18.9% of these patients. The mutations were 69.9% EGFR, 26.3% ALK, 1.6% ROS and 2.2% PDL. Mutations were higher in women and non-smokers (p<0.000, p<0.001). Again, the frequency of mutations in adenocarcinoma was higher in metastatic disease. There was no difference between the patient's age, area of residence, comorbidity and clinical stage and mutation frequency. Our study revealed that the EGFR mutation rate in Turkey with NSCLC was similar to East European, African-American and Caucasian patients, and was lower than in East Asia.

15 June 2021 in Tuberk Toraks
Verified
Journal Article
Closed access
MGMine Gayaf
Mine Gayaf
CACeyda Anar
Ceyda Anar
MCMustafa Canbaz
Mustafa Canbaz
BDBetül İkbal Doğan
Betül İkbal Doğan
AEAhmet Emin Erbaycu
Ahmet Emin Erbaycu
FGFiliz Güldaval
Filiz Güldaval
The aim of this study was to evaluate the predictive power of LENT (LDH in pleural fluid, Eastern Cooperative Oncology Group [ECOG] performance status, neutrophil-lymphocyte ratio in the serum, and tumor type) score which is a current prognostic score in patients with MPE and to determine its effect on survival and its status in clinical decision making. In addition, it was aimed to compare LENT score with the conventional but subjective score ECOG. A retrospective observational study was conducted reviewing the medical records of patients managed for MPE (malign pleural effusion) between 2008 and 2018. LENT prognostic score was calculated in the patients. The ECOG score calculated for the same patients was compared in terms of mortality. A total of 191 patients with malignant pleural effusion, 118 males (61.7%) and 73 females (38.2%), were included in the study. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for identifying overall survival were 69.8 %, 100%, 100% and 18.8%, respectively at the LENT score > 4 (p= 0.000). At ECOG PS >2, the sensitivity, specificity, PPV, NPV were as the same as the LENT score >4 for identifying overall survival. In all patients, overall median survival according to the LENT score was 662/119/33 days in low/moderate/high risk groups, respectively. Cox regression analysis indicated that having a moderate LENT score (p= 0.004, OR: 2.21, CI: 1.29 -3.78%) and high LENT score (p= 0.000, OR: 4, 50 CI: 2.57-7.89%) were predictors for overall survival in all patients due to MPE. In ROC analysis, there was no difference in mortality in erms of both LENT and ECOG at 1st, 6th and 12th months. LENT is a better scoring system than ECOG in predicting early mortality, while both ECOG and LENT have almost the same power in predicting mortality. However, LENT is slightly more objective but more difficult to calculate because it contains laboratory findings. Thus, both scoring systems can be used to predict mortality in patients with malignant pleural effusions. Neither of them has superiority to each other.

26 March 2024 in Tuberk Toraks
Verified
Journal Article
Open access
MGMine Gayaf
Mine Gayaf
MTMerve Ayık Türk
Merve Ayık Türk
OOOzer Ozdemir
Ozer Ozdemir
GEGülru Erbay
Gülru Erbay
OKOnur Karaman
Onur Karaman
AEAhmet Emin Erbaycu
Ahmet Emin Erbaycu
Introduction: Tuberculosis (TB) is an infectious disease that can be fatal if left untreated or poorly treated, and it is associated with many morbidities. Deaths may provide better understanding of the associated factors and help guide interventions to reduce mortality. In this study, it was aimed to reveal some of the features that predict hospital mortality in patients with TB and to present some alarming findings for clinicians. Materials and Methods: Patients who had been hospitalized with the diagnosis of TB between January 2008 and December 2018 were included and analyzed retrospectively. In -hospital mortality because of any TB disease after the initiation of treatment in patients admitted to the TB Ward and the primary cause of mortality were taken as endpoint. Results: A total of 1321 patients with a mean age of 50.1 years were examined. Total mortality was 39.4% (521 deaths) and 13.1% were in -hospital deaths (173 deaths). Of the deaths, 61.8% (n= 107) occurred during the first month after TB treatment were started. On univariate analysis, age over 48.5 years, Charlson comorbidity index, extension of radiological involvement, hypoalbuminemia and lymphopenia were most predictive variables with higher odds ratios (respectively, p< 0.001 for all). Conclusion: In -hospital tuberculosis disease mortality is related with older age, cavitary or extensive pulmonary involvement, low albumin levels, unemployment, cigarette smoking and especially those with concomitant malignancy and chronic pulmonary disease.

1 May 2022 in Turkish Thoracic Journal
Verified
Journal Article
Open access
FÜFatma Demirci Üçsular
Fatma Demirci Üçsular
GKGülistan Karadeniz
Gülistan Karadeniz
GEGülru Erbay
Gülru Erbay
AAAYSU AYRANCI
AYSU AYRANCI
EYEnver Yalniz
Enver Yalniz
CACeyda Anar
Ceyda Anar
Comorbidity,COVID-19,elderly patient,mortality

15 September 2020 in Tuberk Toraks
Verified
Journal Article
Closed access
FGFiliz Güldaval
Filiz Güldaval
CACeyda Anar
Ceyda Anar
MGMine Gayaf
Mine Gayaf
MBMelih Büyükşirin
Melih Büyükşirin
GEGülru Erbay
Gülru Erbay
ÖBözgür Batum
özgür Batum
Introduction: the aim of this study is to investigate and report on the data regarding the clinical characteristics and outcomes of healthcare workers with COVID-19 at tertiary education hospitals from Turkey. Materials and Methods: This was a single center, retrospective, descriptive and observational study using cross-sectional data, which were collected from confirmed COVID-19 patients at a tertiary education hospital. Patients' demographic and clinical characteristics, mortality rates, and the factors associated with hospitalization were analyzed. Results: By May 15, 2020, 480 patients were diagnosed with COVID-19 in our hospital where 49 (10.2%) of whom were HCWs. The mean age was 40.0 +/- 8.45 (75.5% female). The most common symptoms were cough (32.7%), fever (30.6%), and myalgia (14.3%). Comorbidities were present in 32.7% of the patients. Most of the HCWs were nurses (53.1%) and physicians (18.4%), and the remaining 14 (28.6%) were cleaning and administrative staff. The severity of the disease was mild in 65.3% and severe in 34.7% HCWs. Leukocyte, neutrophil, lymphocyte and platelet values were statistically lower in hospitalized patients. There was a statistically significant relationship between the presence of infiltration on the chest X-ray, and the patient's symptoms with the severity of the disease (respectively p= 0.002 and 0.009). Conclusion: In conclusion, the frequency of COVID-19 in healthcare workers is high. The study presents the characteristics of HCWs infected with coronavirus from a single center in Turkey.